Global Phototherapy Market By Offering (Products (Portable, Non-Portable), Services); By Application (Skin Disorders (Psoriasis, Vitiligo, Eczema, Scleroderma, Others), Mood and Sleep Disorders (Seasonal Affective Disorder (SAD), Circadian Rhythm Sleep Disorders), Cancers and Precancers, Diseases in New Born Babies); By End-Use (Home Users, Hospital and Speciality Clinics, Others); By Phototherapy Type (UVB (Broad Band UVB, Narrow Band UVB), PUVA, UVA1, Others); By Sales Channel (Online, Offline); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Phototherapy is a non-invasive medical treatment which has been deployed since 1958 and it involves exposure to fluorescent light bulbs or other light sources such as sunlight, halogen lights and light emitting diodes (LEDs) to treat various conditions including skin disorders, mood and sleep disorders, hyperbilirubinemia and jaundice amongst others. Natural sunlight has been considered useful in treating certain skin disorders for many years, and it is the ultraviolet part of the radiation which is produced by the sun that is used in phototherapy technique, in particular the ultraviolet A (UVA) and ultraviolet B (UVB) wavelengths of light. This technique can be either applied to a specific area or a part of the body, in cases where more than 5% of the skin is affected. There are different types of phototherapy techniques namely UVB (Narrow Band and Broad Band), PUVA (Psoralen + UVA), UVA1 amongst others that are being used to treat medical conditions, which is propelling the phototherapy market. For example UVB is mainly used to treat common skin conditions namely psoriasis, polymorphic light eruption, atopic eczema, generalised itching, pityriasis lichenoides, lichen planus, cutaneous T cell lymphoma and vitiligo amongst others. PUVA is suggested for chronic plaque psoriasis in cases where UVB is not effective. It is also used in treating polymorphic light eruption, vitiligo and cutaneous T-cell lymphoma, as it is considered more potent compared to UVB.
The factors that are influencing the rising demand for phototherapy market include increasing incidences of neonatal hyperbilirubinemia, global skin diseases burden and rising cases of cancers amongst others. Skin disorders are ranked as the fourth common causes of disease worldwide. Approximately 7.5 million people are infected with psoriasis in the United States alone, mainly prevalent between the age group 45 and 64. Skin cancer is one of the most common diseases in the U.S., wherein melanoma is the most growing form of skin cancer. In 2019, 7,230 deaths were recorded due to melanoma cases out of which 4,740 were men and the rest women. Photodynamic therapy, which is a kind of phototherapy is used to treat a few forms of cancer and precancers. This technique uses a particular type of drug called as a photosensitizer in combination with light. Photosensitizers produce certain kind of active oxygen, when exposed to certain wavelengths enabling in killing nearby cells. Thus, this is creating huge growth opportunities for the global phototherapy market.
In terms of revenue, global phototherapy market was valued at USD 598.34 Mn in 2020 and it is anticipated to grow at a CAGR of 6.78% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Offerings Outlook:
Based on offerings, the product segment accounted for the major market share in the global phototherapy market in 2020, whereas services segment is expected to grow at the fastest CAGR over the forecast period. The product category growth is attributed to wide adoption of portable devices in homecare settings.
Application Outlook:
Based on application in the global phototherapy market skin disorders accounted for the major market share in 2020. For treating skin disorders via phototherapy there are three common type of techniques that are used namely Broadband UVB, Narrowband UVB and PUVA. Broadband UVB (BUVB) assists in treating skin diseases such as psoriasis and eczema with the help of full spectrum of ultraviolet-B radiation. Narrowband UVB is more frequently used in comparison to BUVB as this technique is considered to be more efficient to treat psoriasis, which is one of the fastest growing skin disorder. Apart from psoriasis, it is also used to treat eczema, vitiligo, and mycosis fungoides. There is an increase in skin disorders among healthcare workers, owing to COVID-19 pandemic with the usage of PPE kits, causing increase in acne flares, rosacea and seborrheic dermatitis. Additionally, various skin disorders have emerged more during the pandemic mainly owing to the usage of PPE, virus infection, extra hygiene measures and pre-existing skin infections.
Region Outlook:
Based on regions, North America accounted for the highest market share in 2020 in the global phototherapy market. This growth can be attributed to the rising research and development activities being carried for the treatment of cancer and several other malignant disease. Additionally, skin disorders is among the serious concerns in the U.S. with psoriasis accounting for the major share. Rising technological advancements along with world-class healthcare infrastructure is another factor leading for the growth of North America.
Competitive Landscape
The report provides both, qualitative and quantitative research of global phototherapy market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the phototherapy market are Atom Medical Corp, Daavlin, Drägerwerk AG & Co., GENERAL ELECTRIC COMPANY, Ibis Medical, National Biological Corporation, Natus Medical Incorporated, NeoMedLight, Philips Lighting Holding B.V., Phoenix Medical Systems (P) Ltd, Solarc Systems Inc. and Waldmann Group, amongst others.
Global Phototherapy Market:
By Offering
- Products
- Portable
- Non-Portable
- Services
By Application
- Skin Disorders
- Psoriasis
- Vitiligo
- Eczema
- Scleroderma
- Others
- Mood and Sleep Disorders
- Seasonal Affective Disorder (SAD)
- Circadian Rhythm Sleep Disorders
- Cancers and Precancers
- Diseases in New Born Babies
By End-Use
- Home Users
- Hospital and Speciality Clinics
- Others
By Phototherapy Type
- UVB
- Broad Band UVB
- Narrow Band UVB
- PUVA
- UVA1
- Others
By Sales Channel
- Online
- Offline
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Phototherapy Market
6.
Market
Synopsis: Phototherapy Market
7.
Phototherapy
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Phototherapy Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Phototherapy Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Phototherapy Market
8.
Global Phototherapy
Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global Phototherapy Market Revenue (US$ Mn)
8.2. Global Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
8.2.1. Products (Definition, Market Estimation and
Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Portable, Non-Portable)
8.2.1.1.
Portable
8.2.1.2.
Non-Portable
8.2.2. Services
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.2.3.
Market
Forecast, 2021 - 2029
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2020
8.2.2.5.1.2. Market Forecast, 2021 - 2029
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2020
8.2.2.5.2.2. Market Forecast, 2021 - 2029
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2020
8.2.2.5.3.2. Market Forecast, 2021 - 2029
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2020
8.2.2.5.4.2. Market Forecast, 2021 - 2029
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2020
8.2.2.5.5.2. Market Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Offerings
9.
Global
Phototherapy Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
9.2.1. UVB (Definition, Market Estimation and
Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Broad Band UVB, Narrow Band UVB)
9.2.1.1.
Broad
Band UVB
9.2.1.2.
Narrow
Band UVB
9.2.2. PUVA
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.2.3.
Market
Forecast, 2021 - 2029
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2020
9.2.2.5.1.2. Market Forecast, 2021 - 2029
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2020
9.2.2.5.2.2. Market Forecast, 2021 - 2029
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2020
9.2.2.5.3.2. Market Forecast, 2021 - 2029
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2020
9.2.2.5.4.2. Market Forecast, 2021 - 2029
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2020
9.2.2.5.5.2. Market Forecast, 2021 - 2029
9.2.3. UAV1
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.3.3.
Market
Forecast, 2021 - 2029
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2020
9.2.3.5.1.2. Market Forecast, 2021 - 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2020
9.2.3.5.2.2. Market Forecast, 2021 - 2029
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2020
9.2.3.5.3.2. Market Forecast, 2021 - 2029
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2020
9.2.3.5.4.2. Market Forecast, 2021 - 2029
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2020
9.2.3.5.5.2. Market Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.4.3.
Market
Forecast, 2021 - 2029
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2020
9.2.4.5.1.2. Market Forecast, 2021 - 2029
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2020
9.2.4.5.2.2. Market Forecast, 2021 - 2029
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2020
9.2.4.5.3.2. Market Forecast, 2021 - 2029
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2020
9.2.4.5.4.2. Market Forecast, 2021 - 2029
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2020
9.2.4.5.5.2. Market Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By Phototherapy Type
10. Global Phototherapy Market Analysis and
Forecasts, 2021 – 2029
10.1. Overview
10.2. Global Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
10.2.1. Skin Disorders (Definition, Market Estimation
and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Psoriasis, Vitiligo, Eczema, Scleroderma, Others)
10.2.1.1. Psoriasis
10.2.1.2. Vitiligo
10.2.1.3. Eczema
10.2.1.4. Scleroderma
10.2.1.5. Others
10.2.2. Mood and Sleep Disorders (Definition, Market
Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020),
Market Forecast (2021 - 2029), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Seasonal Affective Disorder (SAD), Circadian Rhythm
Sleep Disorders)
10.2.2.1. Seasonal Affective Disorder (SAD)
10.2.2.2. Circadian Rhythm Sleep Disorders
10.2.3. Cancers and Precancers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2020
10.2.3.5.1.2. Market Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2020
10.2.3.5.2.2. Market Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2020
10.2.3.5.3.2. Market Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2020
10.2.3.5.4.2. Market Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2020
10.2.3.5.5.2. Market Forecast, 2021 - 2029
10.2.4. Diseases in New Born Babies
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2020
10.2.4.5.1.2. Market Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2020
10.2.4.5.2.2. Market Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2020
10.2.4.5.3.2. Market Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2020
10.2.4.5.4.2. Market Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2020
10.2.4.5.5.2. Market Forecast, 2021 - 2029
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Phototherapy Market Analysis and
Forecasts, 2021 – 2029
11.1. Overview
11.2. Global Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
11.2.1. Online
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 -
2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2020
11.2.1.5.1.2. Market Forecast, 2021 - 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2020
11.2.1.5.2.2. Market Forecast, 2021 - 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2020
11.2.1.5.3.2. Market Forecast, 2021 - 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2020
11.2.1.5.4.2. Market Forecast, 2021 - 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2020
11.2.1.5.5.2. Market Forecast, 2021 - 2029
11.2.2. Offline
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 -
2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2020
11.2.2.5.1.2. Market Forecast, 2021 - 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2020
11.2.2.5.2.2. Market Forecast, 2021 - 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2020
11.2.2.5.3.2. Market Forecast, 2021 - 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2020
11.2.2.5.4.2. Market Forecast, 2021 - 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2020
11.2.2.5.5.2. Market Forecast, 2021 - 2029
11.3. Key Segment for Channeling Investments
11.3.1. By Sales Channel
12. Global Phototherapy Market Analysis and
Forecasts, 2021 – 2029
12.1. Overview
12.2. Global Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
12.2.1. Home Users
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 -
2020
12.2.1.3. Market Forecast, 2021 - 2029
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market Estimation, 2015 - 2020
12.2.1.5.1.2. Market Forecast, 2021 - 2029
12.2.1.5.2. Europe
12.2.1.5.2.1. Market Estimation, 2015 - 2020
12.2.1.5.2.2. Market Forecast, 2021 - 2029
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market Estimation, 2015 - 2020
12.2.1.5.3.2. Market Forecast, 2021 - 2029
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market Estimation, 2015 - 2020
12.2.1.5.4.2. Market Forecast, 2021 - 2029
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market Estimation, 2015 - 2020
12.2.1.5.5.2. Market Forecast, 2021 - 2029
12.2.2. Hospitals and Specialty Clinics
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 -
2020
12.2.2.3. Market Forecast, 2021 - 2029
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market Estimation, 2015 - 2020
12.2.2.5.1.2. Market Forecast, 2021 - 2029
12.2.2.5.2. Europe
12.2.2.5.2.1. Market Estimation, 2015 - 2020
12.2.2.5.2.2. Market Forecast, 2021 - 2029
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market Estimation, 2015 - 2020
12.2.2.5.3.2. Market Forecast, 2021 - 2029
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market Estimation, 2015 - 2020
12.2.2.5.4.2. Market Forecast, 2021 - 2029
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market Estimation, 2015 - 2020
12.2.2.5.5.2. Market Forecast, 2021 - 2029
12.2.3. Others
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 -
2020
12.2.3.3. Market Forecast, 2021 - 2029
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market Estimation, 2015 - 2020
12.2.3.5.1.2. Market Forecast, 2021 - 2029
12.2.3.5.2. Europe
12.2.3.5.2.1. Market Estimation, 2015 - 2020
12.2.3.5.2.2. Market Forecast, 2021 - 2029
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market Estimation, 2015 - 2020
12.2.3.5.3.2. Market Forecast, 2021 - 2029
12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market Estimation, 2015 - 2020
12.2.3.5.4.2. Market Forecast, 2021 - 2029
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market Estimation, 2015 - 2020
12.2.3.5.5.2. Market Forecast, 2021 - 2029
12.3. Key Segment for Channeling Investments
12.3.1. By End-Use
13. North America Phototherapy Market Analysis
and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. North America Phototherapy Market Revenue
(US$ Mn)
13.2. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
13.2.1. Products
13.2.1.1. Portable
13.2.1.2. Non-Portable
13.2.2. Services
13.3. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
13.3.1. UVB
13.3.1.1. Broad Band UVB
13.3.1.2. Narrow Band UVB
13.3.2. PUVA
13.3.3. UAV1
13.3.4. Others
13.4. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.1. Skin Disorders
13.4.1.1. Psoriasis
13.4.1.2. Vitiligo
13.4.1.3. Eczema
13.4.1.4. Scleroderma
13.4.1.5. Others
13.4.2. Mood and Sleep Disorders
13.4.2.1. Seasonal Affective Disorder (SAD)
13.4.2.2. Circadian Rhythm Sleep Disorders
13.4.3. Cancers and Precancers
13.4.4. Diseases in New Born Babies
13.5. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
13.5.1. Online
13.5.2. Offline
13.6. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
13.6.1. Home Users
13.6.2. Hospitals and Specialty Clinics
13.6.3. Others
13.7. North America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.7.1.1.1. Products
13.7.1.1.1.1. Portable
13.7.1.1.1.2. Non-Portable
13.7.1.1.2. Services
13.7.1.2. U.S Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Phototherapy Type
13.7.1.2.1. UVB
13.7.1.2.1.1. Broad Band UVB
13.7.1.2.1.2. Narrow Band UVB
13.7.1.2.2. PUVA
13.7.1.2.3. UAV1
13.7.1.2.4. Others
13.7.1.3. U.S Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.1.3.1. Skin Disorders
13.7.1.3.1.1. Psoriasis
13.7.1.3.1.2. Vitiligo
13.7.1.3.1.3. Eczema
13.7.1.3.1.4. Scleroderma
13.7.1.3.1.5. Others
13.7.1.3.2. Mood and Sleep Disorders
13.7.1.3.2.1. Seasonal Affective Disorder (SAD)
13.7.1.3.2.2. Circadian Rhythm Sleep Disorders
13.7.1.3.3. Cancers and Precancers
13.7.1.3.4. Diseases in New Born Babies
13.7.1.4. U.S Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
13.7.1.4.1. Online
13.7.1.4.2. Offline
13.7.1.5. U.S Phototherapy Market Revenue (US$ Mn) and
Forecasts, By End-Use
13.7.1.5.1. Home Users
13.7.1.5.2. Hospitals and Specialty Clinics
13.7.1.5.3. Others
13.7.2. Canada
13.7.2.1. Canada Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.7.2.1.1. Products
13.7.2.1.1.1. Portable
13.7.2.1.1.2. Non-Portable
13.7.2.1.2. Services
13.7.2.2. Canada Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
13.7.2.2.1. UVB
13.7.2.2.1.1. Broad Band UVB
13.7.2.2.1.2. Narrow Band UVB
13.7.2.2.2. PUVA
13.7.2.2.3. UAV1
13.7.2.2.4. Others
13.7.2.3. Canada Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
13.7.2.3.1. Skin Disorders
13.7.2.3.1.1. Psoriasis
13.7.2.3.1.2. Vitiligo
13.7.2.3.1.3. Eczema
13.7.2.3.1.4. Scleroderma
13.7.2.3.1.5. Others
13.7.2.3.2. Mood and Sleep Disorders
13.7.2.3.2.1. Seasonal Affective Disorder (SAD)
13.7.2.3.2.2. Circadian Rhythm Sleep Disorders
13.7.2.3.3. Cancers and Precancers
13.7.2.3.4. Diseases in New Born Babies
13.7.2.4. Canada Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.7.2.4.1. Online
13.7.2.4.2. Offline
13.7.2.5. Canada Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
13.7.2.5.1. Home Users
13.7.2.5.2. Hospitals and Specialty Clinics
13.7.2.5.3. Others
13.7.3. Mexico
13.7.3.1. Mexico Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.7.3.1.1. Products
13.7.3.1.1.1. Portable
13.7.3.1.1.2. Non-Portable
13.7.3.1.2. Services
13.7.3.2. Mexico Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
13.7.3.2.1. UVB
13.7.3.2.1.1. Broad Band UVB
13.7.3.2.1.2. Narrow Band UVB
13.7.3.2.2. PUVA
13.7.3.2.3. UAV1
13.7.3.2.4. Others
13.7.3.3. Mexico Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
13.7.3.3.1. Skin Disorders
13.7.3.3.1.1. Psoriasis
13.7.3.3.1.2. Vitiligo
13.7.3.3.1.3. Eczema
13.7.3.3.1.4. Scleroderma
13.7.3.3.1.5. Others
13.7.3.3.2. Mood and Sleep Disorders
13.7.3.3.2.1. Seasonal Affective Disorder (SAD)
13.7.3.3.2.2. Circadian Rhythm Sleep Disorders
13.7.3.3.3. Cancers and Precancers
13.7.3.3.4. Diseases in New Born Babies
13.7.3.4. Mexico Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
13.7.3.4.1. Online
13.7.3.4.2. Offline
13.7.3.5. Mexico Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
13.7.3.5.1. Home Users
13.7.3.5.2. Hospitals and Specialty Clinics
13.7.3.5.3. Others
13.7.4. Rest of North America
13.7.4.1. Rest of North America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Offerings
13.7.4.1.1. Products
13.7.4.1.1.1. Portable
13.7.4.1.1.2. Non-Portable
13.7.4.1.2. Services
13.7.4.2. Rest of North America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Phototherapy Type
13.7.4.2.1. UVB
13.7.4.2.1.1. Broad Band UVB
13.7.4.2.1.2. Narrow Band UVB
13.7.4.2.2. PUVA
13.7.4.2.3. UAV1
13.7.4.2.4. Others
13.7.4.3. Rest of North America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Application
13.7.4.3.1. Skin Disorders
13.7.4.3.1.1. Psoriasis
13.7.4.3.1.2. Vitiligo
13.7.4.3.1.3. Eczema
13.7.4.3.1.4. Scleroderma
13.7.4.3.1.5. Others
13.7.4.3.2. Mood and Sleep Disorders
13.7.4.3.2.1. Seasonal Affective Disorder (SAD)
13.7.4.3.2.2. Circadian Rhythm Sleep Disorders
13.7.4.3.3. Cancers and Precancers
13.7.4.3.4. Diseases in New Born Babies
13.7.4.4. Rest of North America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
13.7.4.4.1. Online
13.7.4.4.2. Offline
13.7.4.5. Rest of North America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By End-Use
13.7.4.5.1. Home Users
13.7.4.5.2. Hospitals and Specialty Clinics
13.7.4.5.3. Others
13.8. Key Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Offerings
13.8.3. By Phototherapy Type
13.8.4. By Application
13.8.5. By Sales Channel
13.8.6. By End-Use
14. Europe Phototherapy Market Analysis and
Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Europe Phototherapy Market Revenue (US$ Mn)
14.2. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.2.1. Products
14.2.1.1. Portable
14.2.1.2. Non-Portable
14.2.2. Services
14.3. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.3.1. UVB
14.3.1.1. Broad Band UVB
14.3.1.2. Narrow Band UVB
14.3.2. PUVA
14.3.3. UAV1
14.3.4. Others
14.4. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.1. Skin Disorders
14.4.1.1. Psoriasis
14.4.1.2. Vitiligo
14.4.1.3. Eczema
14.4.1.4. Scleroderma
14.4.1.5. Others
14.4.2. Mood and Sleep Disorders
14.4.2.1. Seasonal Affective Disorder (SAD)
14.4.2.2. Circadian Rhythm Sleep Disorders
14.4.3. Cancers and Precancers
14.4.4. Diseases in New Born Babies
14.5. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.5.1. Online
14.5.2. Offline
14.6. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.6.1. Home Users
14.6.2. Hospitals and Specialty Clinics
14.6.3. Others
14.7. Europe Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Country
14.7.1. France
14.7.1.1. France Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.1.1.1. Products
14.7.1.1.1.1. Portable
14.7.1.1.1.2. Non-Portable
14.7.1.1.2. Services
14.7.1.2. France Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.7.1.2.1. UVB
14.7.1.2.1.1. Broad Band UVB
14.7.1.2.1.2. Narrow Band UVB
14.7.1.2.2. PUVA
14.7.1.2.3. UAV1
14.7.1.2.4. Others
14.7.1.3. France Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.1.3.1. Skin Disorders
14.7.1.3.1.1. Psoriasis
14.7.1.3.1.2. Vitiligo
14.7.1.3.1.3. Eczema
14.7.1.3.1.4. Scleroderma
14.7.1.3.1.5. Others
14.7.1.3.2. Mood and Sleep Disorders
14.7.1.3.2.1. Seasonal Affective Disorder (SAD)
14.7.1.3.2.2. Circadian Rhythm Sleep Disorders
14.7.1.3.3. Cancers and Precancers
14.7.1.3.4. Diseases in New Born Babies
14.7.1.4. France Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.7.1.4.1. Online
14.7.1.4.2. Offline
14.7.1.5. France Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.7.1.5.1. Home Users
14.7.1.5.2. Hospitals and Specialty Clinics
14.7.1.5.3. Others
14.7.2. The UK
14.7.2.1. The UK Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.2.1.1. Products
14.7.2.1.1.1. Portable
14.7.2.1.1.2. Non-Portable
14.7.2.1.2. Services
14.7.2.2. The UK Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.7.2.2.1. UVB
14.7.2.2.1.1. Broad Band UVB
14.7.2.2.1.2. Narrow Band UVB
14.7.2.2.2. PUVA
14.7.2.2.3. UAV1
14.7.2.2.4. Others
14.7.2.3. The UK Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.2.3.1. Skin Disorders
14.7.2.3.1.1. Psoriasis
14.7.2.3.1.2. Vitiligo
14.7.2.3.1.3. Eczema
14.7.2.3.1.4. Scleroderma
14.7.2.3.1.5. Others
14.7.2.3.2. Mood and Sleep Disorders
14.7.2.3.2.1. Seasonal Affective Disorder (SAD)
14.7.2.3.2.2. Circadian Rhythm Sleep Disorders
14.7.2.3.3. Cancers and Precancers
14.7.2.3.4. Diseases in New Born Babies
14.7.2.4. The UK Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.7.2.4.1. Online
14.7.2.4.2. Offline
14.7.2.5. The UK Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.7.2.5.1. Home Users
14.7.2.5.2. Hospitals and Specialty Clinics
14.7.2.5.3. Others
14.7.3. Spain
14.7.3.1. Spain Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.3.1.1. Products
14.7.3.1.1.1. Portable
14.7.3.1.1.2. Non-Portable
14.7.3.1.2. Services
14.7.3.2. Spain Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.7.3.2.1. UVB
14.7.3.2.1.1. Broad Band UVB
14.7.3.2.1.2. Narrow Band UVB
14.7.3.2.2. PUVA
14.7.3.2.3. UAV1
14.7.3.2.4. Others
14.7.3.3. Spain Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.3.3.1. Skin Disorders
14.7.3.3.1.1. Psoriasis
14.7.3.3.1.2. Vitiligo
14.7.3.3.1.3. Eczema
14.7.3.3.1.4. Scleroderma
14.7.3.3.1.5. Others
14.7.3.3.2. Mood and Sleep Disorders
14.7.3.3.2.1. Seasonal Affective Disorder (SAD)
14.7.3.3.2.2. Circadian Rhythm Sleep Disorders
14.7.3.3.3. Cancers and Precancers
14.7.3.3.4. Diseases in New Born Babies
14.7.3.4. Spain Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.7.3.4.1. Online
14.7.3.4.2. Offline
14.7.3.5. Spain Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.7.3.5.1. Home Users
14.7.3.5.2. Hospitals and Specialty Clinics
14.7.3.5.3. Others
14.7.4. Germany
14.7.4.1. Germany Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.4.1.1. Products
14.7.4.1.1.1. Portable
14.7.4.1.1.2. Non-Portable
14.7.4.1.2. Services
14.7.4.2. Germany Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.7.4.2.1. UVB
14.7.4.2.1.1. Broad Band UVB
14.7.4.2.1.2. Narrow Band UVB
14.7.4.2.2. PUVA
14.7.4.2.3. UAV1
14.7.4.2.4. Others
14.7.4.3. Germany Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.4.3.1. Skin Disorders
14.7.4.3.1.1. Psoriasis
14.7.4.3.1.2. Vitiligo
14.7.4.3.1.3. Eczema
14.7.4.3.1.4. Scleroderma
14.7.4.3.1.5. Others
14.7.4.3.2. Mood and Sleep Disorders
14.7.4.3.2.1. Seasonal Affective Disorder (SAD)
14.7.4.3.2.2. Circadian Rhythm Sleep Disorders
14.7.4.3.3. Cancers and Precancers
14.7.4.3.4. Diseases in New Born Babies
14.7.4.4. Germany Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.7.4.4.1. Online
14.7.4.4.2. Offline
14.7.4.5. Germany Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.7.4.5.1. Home Users
14.7.4.5.2. Hospitals and Specialty Clinics
14.7.4.5.3. Others
14.7.5. Italy
14.7.5.1. Italy Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.5.1.1. Products
14.7.5.1.1.1. Portable
14.7.5.1.1.2. Non-Portable
14.7.5.1.2. Services
14.7.5.2. Italy Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
14.7.5.2.1. UVB
14.7.5.2.1.1. Broad Band UVB
14.7.5.2.1.2. Narrow Band UVB
14.7.5.2.2. PUVA
14.7.5.2.3. UAV1
14.7.5.2.4. Others
14.7.5.3. Italy Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.5.3.1. Skin Disorders
14.7.5.3.1.1. Psoriasis
14.7.5.3.1.2. Vitiligo
14.7.5.3.1.3. Eczema
14.7.5.3.1.4. Scleroderma
14.7.5.3.1.5. Others
14.7.5.3.2. Mood and Sleep Disorders
14.7.5.3.2.1. Seasonal Affective Disorder (SAD)
14.7.5.3.2.2. Circadian Rhythm Sleep Disorders
14.7.5.3.3. Cancers and Precancers
14.7.5.3.4. Diseases in New Born Babies
14.7.5.4. Italy Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
14.7.5.4.1. Online
14.7.5.4.2. Offline
14.7.5.5. Italy Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
14.7.5.5.1. Home Users
14.7.5.5.2. Hospitals and Specialty Clinics
14.7.5.5.3. Others
14.7.6. Nordic Countries
14.7.6.1. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.7.6.1.1. Products
14.7.6.1.1.1. Portable
14.7.6.1.1.2. Non-Portable
14.7.6.1.2. Services
14.7.6.2. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
14.7.6.2.1. UVB
14.7.6.2.1.1. Broad Band UVB
14.7.6.2.1.2. Narrow Band UVB
14.7.6.2.2. PUVA
14.7.6.2.3. UAV1
14.7.6.2.4. Others
14.7.6.3. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.7.6.3.1. Skin Disorders
14.7.6.3.1.1. Psoriasis
14.7.6.3.1.2. Vitiligo
14.7.6.3.1.3. Eczema
14.7.6.3.1.4. Scleroderma
14.7.6.3.1.5. Others
14.7.6.3.2. Mood and Sleep Disorders
14.7.6.3.2.1. Seasonal Affective Disorder (SAD)
14.7.6.3.2.2. Circadian Rhythm Sleep Disorders
14.7.6.3.3. Cancers and Precancers
14.7.6.3.4. Diseases in New Born Babies
14.7.6.4. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
14.7.6.4.1. Online
14.7.6.4.2. Offline
14.7.6.5. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
14.7.6.5.1. Home Users
14.7.6.5.2. Hospitals and Specialty Clinics
14.7.6.5.3. Others
14.7.6.6. Nordic Countries Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux Union
14.7.7.1. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.7.7.1.1. Products
14.7.7.1.1.1. Portable
14.7.7.1.1.2. Non-Portable
14.7.7.1.2. Services
14.7.7.2. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
14.7.7.2.1. UVB
14.7.7.2.1.1. Broad Band UVB
14.7.7.2.1.2. Narrow Band UVB
14.7.7.2.2. PUVA
14.7.7.2.3. UAV1
14.7.7.2.4. Others
14.7.7.3. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.7.7.3.1. Skin Disorders
14.7.7.3.1.1. Psoriasis
14.7.7.3.1.2. Vitiligo
14.7.7.3.1.3. Eczema
14.7.7.3.1.4. Scleroderma
14.7.7.3.1.5. Others
14.7.7.3.2. Mood and Sleep Disorders
14.7.7.3.2.1. Seasonal Affective Disorder (SAD)
14.7.7.3.2.2. Circadian Rhythm Sleep Disorders
14.7.7.3.3. Cancers and Precancers
14.7.7.3.4. Diseases in New Born Babies
14.7.7.4. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
14.7.7.4.1. Online
14.7.7.4.2. Offline
14.7.7.5. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
14.7.7.5.1. Home Users
14.7.7.5.2. Hospitals and Specialty Clinics
14.7.7.5.3. Others
14.7.7.6. Benelux Union Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of Europe
14.7.8.1. Rest of Europe Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.7.8.1.1. Products
14.7.8.1.1.1. Portable
14.7.8.1.1.2. Non-Portable
14.7.8.1.2. Services
14.7.8.2. Rest of Europe Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
14.7.8.2.1. UVB
14.7.8.2.1.1. Broad Band UVB
14.7.8.2.1.2. Narrow Band UVB
14.7.8.2.2. PUVA
14.7.8.2.3. UAV1
14.7.8.2.4. Others
14.7.8.3. Rest of Europe Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.7.8.3.1. Skin Disorders
14.7.8.3.1.1. Psoriasis
14.7.8.3.1.2. Vitiligo
14.7.8.3.1.3. Eczema
14.7.8.3.1.4. Scleroderma
14.7.8.3.1.5. Others
14.7.8.3.2. Mood and Sleep Disorders
14.7.8.3.2.1. Seasonal Affective Disorder (SAD)
14.7.8.3.2.2. Circadian Rhythm Sleep Disorders
14.7.8.3.3. Cancers and Precancers
14.7.8.3.4. Diseases in New Born Babies
14.7.8.4. Rest of Europe Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
14.7.8.4.1. Online
14.7.8.4.2. Offline
14.7.8.5. Rest of Europe Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
14.7.8.5.1. Home Users
14.7.8.5.2. Hospitals and Specialty Clinics
14.7.8.5.3. Others
14.8. Key Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Offerings
14.8.3. By Phototherapy Type
14.8.4. By Application
14.8.5. By Sales Channel
14.8.6. By End-Use
15. Asia Pacific Phototherapy Market Analysis
and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Asia Pacific Phototherapy Market Revenue (US$
Mn)
15.2. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
15.2.1. Products
15.2.1.1. Portable
15.2.1.2. Non-Portable
15.2.2. Services
15.3. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
15.3.1. UVB
15.3.1.1. Broad Band UVB
15.3.1.2. Narrow Band UVB
15.3.2. PUVA
15.3.3. UAV1
15.3.4. Others
15.4. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
15.4.1. Skin Disorders
15.4.1.1. Psoriasis
15.4.1.2. Vitiligo
15.4.1.3. Eczema
15.4.1.4. Scleroderma
15.4.1.5. Others
15.4.2. Mood and Sleep Disorders
15.4.2.1. Seasonal Affective Disorder (SAD)
15.4.2.2. Circadian Rhythm Sleep Disorders
15.4.3. Cancers and Precancers
15.4.4. Diseases in New Born Babies
15.5. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
15.5.1. Online
15.5.2. Offline
15.6. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
15.6.1. Home Users
15.6.2. Hospitals and Specialty Clinics
15.6.3. Others
15.7. Asia Pacific Phototherapy Market Revenue (US$
Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.7.1.1.1. Products
15.7.1.1.1.1. Portable
15.7.1.1.1.2. Non-Portable
15.7.1.1.2. Services
15.7.1.2. China Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
15.7.1.2.1. UVB
15.7.1.2.1.1. Broad Band UVB
15.7.1.2.1.2. Narrow Band UVB
15.7.1.2.2. PUVA
15.7.1.2.3. UAV1
15.7.1.2.4. Others
15.7.1.3. China Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.1.3.1. Skin Disorders
15.7.1.3.1.1. Psoriasis
15.7.1.3.1.2. Vitiligo
15.7.1.3.1.3. Eczema
15.7.1.3.1.4. Scleroderma
15.7.1.3.1.5. Others
15.7.1.3.2. Mood and Sleep Disorders
15.7.1.3.2.1. Seasonal Affective Disorder (SAD)
15.7.1.3.2.2. Circadian Rhythm Sleep Disorders
15.7.1.3.3. Cancers and Precancers
15.7.1.3.4. Diseases in New Born Babies
15.7.1.4. China Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
15.7.1.4.1. Online
15.7.1.4.2. Offline
15.7.1.5. China Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
15.7.1.5.1. Home Users
15.7.1.5.2. Hospitals and Specialty Clinics
15.7.1.5.3. Others
15.7.2. Japan
15.7.2.1. Japan Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.7.2.1.1. Products
15.7.2.1.1.1. Portable
15.7.2.1.1.2. Non-Portable
15.7.2.1.2. Services
15.7.2.2. Japan Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
15.7.2.2.1. UVB
15.7.2.2.1.1. Broad Band UVB
15.7.2.2.1.2. Narrow Band UVB
15.7.2.2.2. PUVA
15.7.2.2.3. UAV1
15.7.2.2.4. Others
15.7.2.3. Japan Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.2.3.1. Skin Disorders
15.7.2.3.1.1. Psoriasis
15.7.2.3.1.2. Vitiligo
15.7.2.3.1.3. Eczema
15.7.2.3.1.4. Scleroderma
15.7.2.3.1.5. Others
15.7.2.3.2. Mood and Sleep Disorders
15.7.2.3.2.1. Seasonal Affective Disorder (SAD)
15.7.2.3.2.2. Circadian Rhythm Sleep Disorders
15.7.2.3.3. Cancers and Precancers
15.7.2.3.4. Diseases in New Born Babies
15.7.2.4. Japan Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
15.7.2.4.1. Online
15.7.2.4.2. Offline
15.7.2.5. Japan Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
15.7.2.5.1. Home Users
15.7.2.5.2. Hospitals and Specialty Clinics
15.7.2.5.3. Others
15.7.3. India
15.7.3.1. India Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.7.3.1.1. Products
15.7.3.1.1.1. Portable
15.7.3.1.1.2. Non-Portable
15.7.3.1.2. Services
15.7.3.2. India Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
15.7.3.2.1. UVB
15.7.3.2.1.1. Broad Band UVB
15.7.3.2.1.2. Narrow Band UVB
15.7.3.2.2. PUVA
15.7.3.2.3. UAV1
15.7.3.2.4. Others
15.7.3.3. India Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.3.3.1. Skin Disorders
15.7.3.3.1.1. Psoriasis
15.7.3.3.1.2. Vitiligo
15.7.3.3.1.3. Eczema
15.7.3.3.1.4. Scleroderma
15.7.3.3.1.5. Others
15.7.3.3.2. Mood and Sleep Disorders
15.7.3.3.2.1. Seasonal Affective Disorder (SAD)
15.7.3.3.2.2. Circadian Rhythm Sleep Disorders
15.7.3.3.3. Cancers and Precancers
15.7.3.3.4. Diseases in New Born Babies
15.7.3.4. India Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
15.7.3.4.1. Online
15.7.3.4.2. Offline
15.7.3.5. India Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
15.7.3.5.1. Home Users
15.7.3.5.2. Hospitals and Specialty Clinics
15.7.3.5.3. Others
15.7.4. New Zealand
15.7.4.1. New Zealand Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
15.7.4.1.1. Products
15.7.4.1.1.1. Portable
15.7.4.1.1.2. Non-Portable
15.7.4.1.2. Services
15.7.4.2. New Zealand Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
15.7.4.2.1. UVB
15.7.4.2.1.1. Broad Band UVB
15.7.4.2.1.2. Narrow Band UVB
15.7.4.2.2. PUVA
15.7.4.2.3. UAV1
15.7.4.2.4. Others
15.7.4.3. New Zealand Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
15.7.4.3.1. Skin Disorders
15.7.4.3.1.1. Psoriasis
15.7.4.3.1.2. Vitiligo
15.7.4.3.1.3. Eczema
15.7.4.3.1.4. Scleroderma
15.7.4.3.1.5. Others
15.7.4.3.2. Mood and Sleep Disorders
15.7.4.3.2.1. Seasonal Affective Disorder (SAD)
15.7.4.3.2.2. Circadian Rhythm Sleep Disorders
15.7.4.3.3. Cancers and Precancers
15.7.4.3.4. Diseases in New Born Babies
15.7.4.4. New Zealand Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
15.7.4.4.1. Online
15.7.4.4.2. Offline
15.7.4.5. New Zealand Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
15.7.4.5.1. Home Users
15.7.4.5.2. Hospitals and Specialty Clinics
15.7.4.5.3. Others
15.7.5. Australia
15.7.5.1. Australia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
15.7.5.1.1. Products
15.7.5.1.1.1. Portable
15.7.5.1.1.2. Non-Portable
15.7.5.1.2. Services
15.7.5.2. Australia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
15.7.5.2.1. UVB
15.7.5.2.1.1. Broad Band UVB
15.7.5.2.1.2. Narrow Band UVB
15.7.5.2.2. PUVA
15.7.5.2.3. UAV1
15.7.5.2.4. Others
15.7.5.3. Australia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
15.7.5.3.1. Skin Disorders
15.7.5.3.1.1. Psoriasis
15.7.5.3.1.2. Vitiligo
15.7.5.3.1.3. Eczema
15.7.5.3.1.4. Scleroderma
15.7.5.3.1.5. Others
15.7.5.3.2. Mood and Sleep Disorders
15.7.5.3.2.1. Seasonal Affective Disorder (SAD)
15.7.5.3.2.2. Circadian Rhythm Sleep Disorders
15.7.5.3.3. Cancers and Precancers
15.7.5.3.4. Diseases in New Born Babies
15.7.5.4. Australia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
15.7.5.4.1. Online
15.7.5.4.2. Offline
15.7.5.5. Australia Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
15.7.5.5.1. Home Users
15.7.5.5.2. Hospitals and Specialty Clinics
15.7.5.5.3. Others
15.7.6. South Korea
15.7.6.1. South Korea Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
15.7.6.1.1. Products
15.7.6.1.1.1. Portable
15.7.6.1.1.2. Non-Portable
15.7.6.1.2. Services
15.7.6.2. South Korea Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
15.7.6.2.1. UVB
15.7.6.2.1.1. Broad Band UVB
15.7.6.2.1.2. Narrow Band UVB
15.7.6.2.2. PUVA
15.7.6.2.3. UAV1
15.7.6.2.4. Others
15.7.6.3. South Korea Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
15.7.6.3.1. Skin Disorders
15.7.6.3.1.1. Psoriasis
15.7.6.3.1.2. Vitiligo
15.7.6.3.1.3. Eczema
15.7.6.3.1.4. Scleroderma
15.7.6.3.1.5. Others
15.7.6.3.2. Mood and Sleep Disorders
15.7.6.3.2.1. Seasonal Affective Disorder (SAD)
15.7.6.3.2.2. Circadian Rhythm Sleep Disorders
15.7.6.3.3. Cancers and Precancers
15.7.6.3.4. Diseases in New Born Babies
15.7.6.4. South Korea Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
15.7.6.4.1. Online
15.7.6.4.2. Offline
15.7.6.5. South Korea Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
15.7.6.5.1. Home Users
15.7.6.5.2. Hospitals and Specialty Clinics
15.7.6.5.3. Others
15.7.7. Southeast Asia
15.7.7.1. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
15.7.7.1.1. Products
15.7.7.1.1.1. Portable
15.7.7.1.1.2. Non-Portable
15.7.7.1.2. Services
15.7.7.2. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
15.7.7.2.1. UVB
15.7.7.2.1.1. Broad Band UVB
15.7.7.2.1.2. Narrow Band UVB
15.7.7.2.2. PUVA
15.7.7.2.3. UAV1
15.7.7.2.4. Others
15.7.7.3. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
15.7.7.3.1. Skin Disorders
15.7.7.3.1.1. Psoriasis
15.7.7.3.1.2. Vitiligo
15.7.7.3.1.3. Eczema
15.7.7.3.1.4. Scleroderma
15.7.7.3.1.5. Others
15.7.7.3.2. Mood and Sleep Disorders
15.7.7.3.2.1. Seasonal Affective Disorder (SAD)
15.7.7.3.2.2. Circadian Rhythm Sleep Disorders
15.7.7.3.3. Cancers and Precancers
15.7.7.3.4. Diseases in New Born Babies
15.7.7.4. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
15.7.7.4.1. Online
15.7.7.4.2. Offline
15.7.7.5. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
15.7.7.5.1. Home Users
15.7.7.5.2. Hospitals and Specialty Clinics
15.7.7.5.3. Others
15.7.7.6. Southeast Asia Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1. Rest of Asia Pacific Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Offerings
15.7.8.1.1. Products
15.7.8.1.1.1. Portable
15.7.8.1.1.2. Non-Portable
15.7.8.1.2. Services
15.7.8.2. Rest of Asia Pacific Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Phototherapy Type
15.7.8.2.1. UVB
15.7.8.2.1.1. Broad Band UVB
15.7.8.2.1.2. Narrow Band UVB
15.7.8.2.2. PUVA
15.7.8.2.3. UAV1
15.7.8.2.4. Others
15.7.8.3. Rest of Asia Pacific Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Application
15.7.8.3.1. Skin Disorders
15.7.8.3.1.1. Psoriasis
15.7.8.3.1.2. Vitiligo
15.7.8.3.1.3. Eczema
15.7.8.3.1.4. Scleroderma
15.7.8.3.1.5. Others
15.7.8.3.2. Mood and Sleep Disorders
15.7.8.3.2.1. Seasonal Affective Disorder (SAD)
15.7.8.3.2.2. Circadian Rhythm Sleep Disorders
15.7.8.3.3. Cancers and Precancers
15.7.8.3.4. Diseases in New Born Babies
15.7.8.4. Rest of Asia Pacific Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
15.7.8.4.1. Online
15.7.8.4.2. Offline
15.7.8.5. Rest of Asia Pacific Phototherapy Market
Revenue (US$ Mn) and Forecasts, By End-Use
15.7.8.5.1. Home Users
15.7.8.5.2. Hospitals and Specialty Clinics
15.7.8.5.3. Others
15.8. Key Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Offerings
15.8.3. By Phototherapy Type
15.8.4. By Application
15.8.5. By Sales Channel
15.8.6. By End-Use
16. Middle East and Africa Phototherapy Market
Analysis and Forecasts, 2021 - 2029
16.1. Overview
16.1.1. Middle East and Africa Phototherapy Market
Revenue (US$ Mn)
16.2. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Offerings
16.2.1. Products
16.2.1.1. Portable
16.2.1.2. Non-Portable
16.2.2. Services
16.3. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Phototherapy Type
16.3.1. UVB
16.3.1.1. Broad Band UVB
16.3.1.2. Narrow Band UVB
16.3.2. PUVA
16.3.3. UAV1
16.3.4. Others
16.4. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Skin Disorders
16.4.1.1. Psoriasis
16.4.1.2. Vitiligo
16.4.1.3. Eczema
16.4.1.4. Scleroderma
16.4.1.5. Others
16.4.2. Mood and Sleep Disorders
16.4.2.1. Seasonal Affective Disorder (SAD)
16.4.2.2. Circadian Rhythm Sleep Disorders
16.4.3. Cancers and Precancers
16.4.4. Diseases in New Born Babies
16.5. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
16.5.1. Online
16.5.2. Offline
16.6. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By End-Use
16.6.1. Home Users
16.6.2. Hospitals and Specialty Clinics
16.6.3. Others
16.7. Middle East and Africa Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1. Saudi Arabia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
16.7.1.1.1. Products
16.7.1.1.1.1. Portable
16.7.1.1.1.2. Non-Portable
16.7.1.1.2. Services
16.7.1.2. Saudi Arabia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
16.7.1.2.1. UVB
16.7.1.2.1.1. Broad Band UVB
16.7.1.2.1.2. Narrow Band UVB
16.7.1.2.2. PUVA
16.7.1.2.3. UAV1
16.7.1.2.4. Others
16.7.1.3. Saudi Arabia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
16.7.1.3.1. Skin Disorders
16.7.1.3.1.1. Psoriasis
16.7.1.3.1.2. Vitiligo
16.7.1.3.1.3. Eczema
16.7.1.3.1.4. Scleroderma
16.7.1.3.1.5. Others
16.7.1.3.2. Mood and Sleep Disorders
16.7.1.3.2.1. Seasonal Affective Disorder (SAD)
16.7.1.3.2.2. Circadian Rhythm Sleep Disorders
16.7.1.3.3. Cancers and Precancers
16.7.1.3.4. Diseases in New Born Babies
16.7.1.4. Saudi Arabia Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
16.7.1.4.1. Online
16.7.1.4.2. Offline
16.7.1.5. Saudi Arabia Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
16.7.1.5.1. Home Users
16.7.1.5.2. Hospitals and Specialty Clinics
16.7.1.5.3. Others
16.7.2. UAE
16.7.2.1. UAE Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.7.2.1.1. Products
16.7.2.1.1.1. Portable
16.7.2.1.1.2. Non-Portable
16.7.2.1.2. Services
16.7.2.2. UAE Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Phototherapy Type
16.7.2.2.1. UVB
16.7.2.2.1.1. Broad Band UVB
16.7.2.2.1.2. Narrow Band UVB
16.7.2.2.2. PUVA
16.7.2.2.3. UAV1
16.7.2.2.4. Others
16.7.2.3. UAE Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.2.3.1. Skin Disorders
16.7.2.3.1.1. Psoriasis
16.7.2.3.1.2. Vitiligo
16.7.2.3.1.3. Eczema
16.7.2.3.1.4. Scleroderma
16.7.2.3.1.5. Others
16.7.2.3.2. Mood and Sleep Disorders
16.7.2.3.2.1. Seasonal Affective Disorder (SAD)
16.7.2.3.2.2. Circadian Rhythm Sleep Disorders
16.7.2.3.3. Cancers and Precancers
16.7.2.3.4. Diseases in New Born Babies
16.7.2.4. UAE Phototherapy Market Revenue (US$ Mn) and
Forecasts, By Sales Channel
16.7.2.4.1. Online
16.7.2.4.2. Offline
16.7.2.5. UAE Phototherapy Market Revenue (US$ Mn) and
Forecasts, By End-Use
16.7.2.5.1. Home Users
16.7.2.5.2. Hospitals and Specialty Clinics
16.7.2.5.3. Others
16.7.3. Egypt
16.7.3.1. Egypt Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
16.7.3.1.1. Products
16.7.3.1.1.1. Portable
16.7.3.1.1.2. Non-Portable
16.7.3.1.2. Services
16.7.3.2. Egypt Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
16.7.3.2.1. UVB
16.7.3.2.1.1. Broad Band UVB
16.7.3.2.1.2. Narrow Band UVB
16.7.3.2.2. PUVA
16.7.3.2.3. UAV1
16.7.3.2.4. Others
16.7.3.3. Egypt Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
16.7.3.3.1. Skin Disorders
16.7.3.3.1.1. Psoriasis
16.7.3.3.1.2. Vitiligo
16.7.3.3.1.3. Eczema
16.7.3.3.1.4. Scleroderma
16.7.3.3.1.5. Others
16.7.3.3.2. Mood and Sleep Disorders
16.7.3.3.2.1. Seasonal Affective Disorder (SAD)
16.7.3.3.2.2. Circadian Rhythm Sleep Disorders
16.7.3.3.3. Cancers and Precancers
16.7.3.3.4. Diseases in New Born Babies
16.7.3.4. Egypt Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
16.7.3.4.1. Online
16.7.3.4.2. Offline
16.7.3.5. Egypt Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
16.7.3.5.1. Home Users
16.7.3.5.2. Hospitals and Specialty Clinics
16.7.3.5.3. Others
16.7.4. Kuwait
16.7.4.1. Kuwait Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
16.7.4.1.1. Products
16.7.4.1.1.1. Portable
16.7.4.1.1.2. Non-Portable
16.7.4.1.2. Services
16.7.4.2. Kuwait Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
16.7.4.2.1. UVB
16.7.4.2.1.1. Broad Band UVB
16.7.4.2.1.2. Narrow Band UVB
16.7.4.2.2. PUVA
16.7.4.2.3. UAV1
16.7.4.2.4. Others
16.7.4.3. Kuwait Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
16.7.4.3.1. Skin Disorders
16.7.4.3.1.1. Psoriasis
16.7.4.3.1.2. Vitiligo
16.7.4.3.1.3. Eczema
16.7.4.3.1.4. Scleroderma
16.7.4.3.1.5. Others
16.7.4.3.2. Mood and Sleep Disorders
16.7.4.3.2.1. Seasonal Affective Disorder (SAD)
16.7.4.3.2.2. Circadian Rhythm Sleep Disorders
16.7.4.3.3. Cancers and Precancers
16.7.4.3.4. Diseases in New Born Babies
16.7.4.4. Kuwait Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
16.7.4.4.1. Online
16.7.4.4.2. Offline
16.7.4.5. Kuwait Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
16.7.4.5.1. Home Users
16.7.4.5.2. Hospitals and Specialty Clinics
16.7.4.5.3. Others
16.7.5. South Africa
16.7.5.1. South Africa Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
16.7.5.1.1. Products
16.7.5.1.1.1. Portable
16.7.5.1.1.2. Non-Portable
16.7.5.1.2. Services
16.7.5.2. South Africa Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
16.7.5.2.1. UVB
16.7.5.2.1.1. Broad Band UVB
16.7.5.2.1.2. Narrow Band UVB
16.7.5.2.2. PUVA
16.7.5.2.3. UAV1
16.7.5.2.4. Others
16.7.5.3. South Africa Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
16.7.5.3.1. Skin Disorders
16.7.5.3.1.1. Psoriasis
16.7.5.3.1.2. Vitiligo
16.7.5.3.1.3. Eczema
16.7.5.3.1.4. Scleroderma
16.7.5.3.1.5. Others
16.7.5.3.2. Mood and Sleep Disorders
16.7.5.3.2.1. Seasonal Affective Disorder (SAD)
16.7.5.3.2.2. Circadian Rhythm Sleep Disorders
16.7.5.3.3. Cancers and Precancers
16.7.5.3.4. Diseases in New Born Babies
16.7.5.4. South Africa Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
16.7.5.4.1. Online
16.7.5.4.2. Offline
16.7.5.5. South Africa Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
16.7.5.5.1. Home Users
16.7.5.5.2. Hospitals and Specialty Clinics
16.7.5.5.3. Others
16.7.6. Rest of Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Phototherapy
Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.6.1.1. Products
16.7.6.1.1.1. Portable
16.7.6.1.1.2. Non-Portable
16.7.6.1.2. Services
16.7.6.2. Rest of Middle East & Africa Phototherapy
Market Revenue (US$ Mn) and Forecasts, By Phototherapy Type
16.7.6.2.1. UVB
16.7.6.2.1.1. Broad Band UVB
16.7.6.2.1.2. Narrow Band UVB
16.7.6.2.2. PUVA
16.7.6.2.3. UAV1
16.7.6.2.4. Others
16.7.6.3. Rest of Middle East & Africa Phototherapy
Market Revenue (US$ Mn) and Forecasts, By Application
16.7.6.3.1. Skin Disorders
16.7.6.3.1.1. Psoriasis
16.7.6.3.1.2. Vitiligo
16.7.6.3.1.3. Eczema
16.7.6.3.1.4. Scleroderma
16.7.6.3.1.5. Others
16.7.6.3.2. Mood and Sleep Disorders
16.7.6.3.2.1. Seasonal Affective Disorder (SAD)
16.7.6.3.2.2. Circadian Rhythm Sleep Disorders
16.7.6.3.3. Cancers and Precancers
16.7.6.3.4. Diseases in New Born Babies
16.7.6.4. Rest of Middle East & Africa Phototherapy
Market Revenue (US$ Mn) and Forecasts, By Sales Channel
16.7.6.4.1. Online
16.7.6.4.2. Offline
16.7.6.5. Rest of Middle East & Africa Phototherapy
Market Revenue (US$ Mn) and Forecasts, By End-Use
16.7.6.5.1. Home Users
16.7.6.5.2. Hospitals and Specialty Clinics
16.7.6.5.3. Others
16.8. Key Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Offerings
16.8.3. By Phototherapy Type
16.8.4. By Application
16.8.5. By Sales Channel
16.8.6. By End-Use
17. Latin America Phototherapy Market Analysis
and Forecasts, 2021 - 2029
17.1. Overview
17.1.1. Latin America Phototherapy Market Revenue
(US$ Mn)
17.2. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Offerings
17.2.1. Products
17.2.1.1. Portable
17.2.1.2. Non-Portable
17.2.2. Services
17.3. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Phototherapy Type
17.3.1. UVB
17.3.1.1. Broad Band UVB
17.3.1.2. Narrow Band UVB
17.3.2. PUVA
17.3.3. UAV1
17.3.4. Others
17.4. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Application
17.4.1. Skin Disorders
17.4.1.1. Psoriasis
17.4.1.2. Vitiligo
17.4.1.3. Eczema
17.4.1.4. Scleroderma
17.4.1.5. Others
17.4.2. Mood and Sleep Disorders
17.4.2.1. Seasonal Affective Disorder (SAD)
17.4.2.2. Circadian Rhythm Sleep Disorders
17.4.3. Cancers and Precancers
17.4.4. Diseases in New Born Babies
17.5. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Sales Channel
17.5.1. Online
17.5.2. Offline
17.6. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By End-Use
17.6.1. Home Users
17.6.2. Hospitals and Specialty Clinics
17.6.3. Others
17.7. Latin America Phototherapy Market Revenue
(US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Offerings
17.7.1.1.1. Products
17.7.1.1.1.1. Portable
17.7.1.1.1.2. Non-Portable
17.7.1.1.2. Services
17.7.1.2. Brazil Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Phototherapy Type
17.7.1.2.1. UVB
17.7.1.2.1.1. Broad Band UVB
17.7.1.2.1.2. Narrow Band UVB
17.7.1.2.2. PUVA
17.7.1.2.3. UAV1
17.7.1.2.4. Others
17.7.1.3. Brazil Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Application
17.7.1.3.1. Skin Disorders
17.7.1.3.1.1. Psoriasis
17.7.1.3.1.2. Vitiligo
17.7.1.3.1.3. Eczema
17.7.1.3.1.4. Scleroderma
17.7.1.3.1.5. Others
17.7.1.3.2. Mood and Sleep Disorders
17.7.1.3.2.1. Seasonal Affective Disorder (SAD)
17.7.1.3.2.2. Circadian Rhythm Sleep Disorders
17.7.1.3.3. Cancers and Precancers
17.7.1.3.4. Diseases in New Born Babies
17.7.1.4. Brazil Phototherapy Market Revenue (US$ Mn)
and Forecasts, By Sales Channel
17.7.1.4.1. Online
17.7.1.4.2. Offline
17.7.1.5. Brazil Phototherapy Market Revenue (US$ Mn)
and Forecasts, By End-Use
17.7.1.5.1. Home Users
17.7.1.5.2. Hospitals and Specialty Clinics
17.7.1.5.3. Others
17.7.2. Argentina
17.7.2.1. Argentina Phototherapy Market Revenue (US$
Mn) and Forecasts, By Offerings
17.7.2.1.1. Products
17.7.2.1.1.1. Portable
17.7.2.1.1.2. Non-Portable
17.7.2.1.2. Services
17.7.2.2. Argentina Phototherapy Market Revenue (US$
Mn) and Forecasts, By Phototherapy Type
17.7.2.2.1. UVB
17.7.2.2.1.1. Broad Band UVB
17.7.2.2.1.2. Narrow Band UVB
17.7.2.2.2. PUVA
17.7.2.2.3. UAV1
17.7.2.2.4. Others
17.7.2.3. Argentina Phototherapy Market Revenue (US$
Mn) and Forecasts, By Application
17.7.2.3.1. Skin Disorders
17.7.2.3.1.1. Psoriasis
17.7.2.3.1.2. Vitiligo
17.7.2.3.1.3. Eczema
17.7.2.3.1.4. Scleroderma
17.7.2.3.1.5. Others
17.7.2.3.2. Mood and Sleep Disorders
17.7.2.3.2.1. Seasonal Affective Disorder (SAD)
17.7.2.3.2.2. Circadian Rhythm Sleep Disorders
17.7.2.3.3. Cancers and Precancers
17.7.2.3.4. Diseases in New Born Babies
17.7.2.4. Argentina Phototherapy Market Revenue (US$
Mn) and Forecasts, By Sales Channel
17.7.2.4.1. Online
17.7.2.4.2. Offline
17.7.2.5. Argentina Phototherapy Market Revenue (US$
Mn) and Forecasts, By End-Use
17.7.2.5.1. Home Users
17.7.2.5.2. Hospitals and Specialty Clinics
17.7.2.5.3. Others
17.7.3. Rest of Latin America
17.7.3.1. Rest of Latin America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Offerings
17.7.3.1.1. Products
17.7.3.1.1.1. Portable
17.7.3.1.1.2. Non-Portable
17.7.3.1.2. Services
17.7.3.2. Rest of Latin America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Phototherapy Type
17.7.3.2.1. UVB
17.7.3.2.1.1. Broad Band UVB
17.7.3.2.1.2. Narrow Band UVB
17.7.3.2.2. PUVA
17.7.3.2.3. UAV1
17.7.3.2.4. Others
17.7.3.3. Rest of Latin America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Application
17.7.3.3.1. Skin Disorders
17.7.3.3.1.1. Psoriasis
17.7.3.3.1.2. Vitiligo
17.7.3.3.1.3. Eczema
17.7.3.3.1.4. Scleroderma
17.7.3.3.1.5. Others
17.7.3.3.2. Mood and Sleep Disorders
17.7.3.3.2.1. Seasonal Affective Disorder (SAD)
17.7.3.3.2.2. Circadian Rhythm Sleep Disorders
17.7.3.3.3. Cancers and Precancers
17.7.3.3.4. Diseases in New Born Babies
17.7.3.4. Rest of Latin America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By Sales Channel
17.7.3.4.1. Online
17.7.3.4.2. Offline
17.7.3.5. Rest of Latin America Phototherapy Market
Revenue (US$ Mn) and Forecasts, By End-Use
17.7.3.5.1. Home Users
17.7.3.5.2. Hospitals and Specialty Clinics
17.7.3.5.3. Others
17.8. Key Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Offerings
17.8.3. By Phototherapy Type
17.8.4. By Application
17.8.5. By Sales Channel
17.8.6. By End-Use
18. Competitive Benchmarking
18.1. Brand Benchmarking
18.2. Market Share Analysis, 2020
18.3. Global Presence and Growth Strategies
18.3.1. Mergers and Acquisitions
18.3.2. Product Launches
18.3.3. Investments Trends
18.3.4. R&D Initiatives
19. Player Profiles
19.1. Atom Medical Corp
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. Daavlin
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. Drägerwerk AG & Co.
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. GENERAL ELECTRIC COMPANY
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. Ibis Medical
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. National Biological Corporation
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. Natus Medical Incorporated
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. NeoMedLight
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. Philips Lighting Holding B.V.
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. Phoenix Medical Systems (P) Ltd
19.10.1. Company Details
19.10.2. Company Overview
19.10.3. Product Offerings
19.10.4. Key Developments
19.10.5. Financial Analysis
19.10.6. SWOT Analysis
19.10.7. Business Strategies
19.11. Solarc Systems Inc.
19.11.1. Company Details
19.11.2. Company Overview
19.11.3. Product Offerings
19.11.4. Key Developments
19.11.5. Financial Analysis
19.11.6. SWOT Analysis
19.11.7. Business Strategies
19.12. Waldmann Group
19.12.1. Company Details
19.12.2. Company Overview
19.12.3. Product Offerings
19.12.4. Key Developments
19.12.5. Financial Analysis
19.12.6. SWOT Analysis
19.12.7. Business Strategies
19.13. Other Market Participants
20. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
